SVB Leerink Upgrades Elevance Health to Outperform, Raises Price Target to $580
SVB Leerink analyst Whit Mayo upgrades Elevance Health (NYSE:ELV) from Market Perform to Outperform and raises the price target from $490 to $580.
Credit Suisse Upgrades Vipshop Holdings to Outperform, Announces $12 Price Target
Credit Suisse analyst Ashley Xu upgrades Vipshop Holdings (NYSE:VIPS) from Neutral to Outperform and announces $12 price target.
Morgan Stanley Upgrades Foot Locker to Equal-Weight, Raises Price Target to $36
Morgan Stanley analyst Kimberly Greenberger upgrades Foot Locker (NYSE:FL) from Underweight to Equal-Weight and raises the price target from $24 to $36.
Citigroup Upgrades Vipshop Holdings to Neutral, Raises Price Target to $10.9
Citigroup upgrades Vipshop Holdings (NYSE:VIPS) from Sell to Neutral and raises the price target from $7.8 to $10.9.
Why This Foot Locker Analyst Is Encouraged By New CEO
Foot Locker, Inc (NYSE: FL) unexpectedly announced the departure of current CEO Richard Johnson and named former Ulta Beauty Inc (NASDAQ: ULTA) CEO Mary Dillon as his replacement, which is
Citigroup Upgrades Foot Locker to Neutral, Raises Price Target to $38
Citigroup analyst Paul Lejuez upgrades Foot Locker (NYSE:FL) from Sell to Neutral and raises the price target from $25 to $38.
UBS Upgrades DaVita to Buy, Raises Price Target to $117
UBS analyst Andrew Mok upgrades DaVita (NYSE:DVA) from Neutral to Buy and raises the price target from $106 to $117.
Piper Sandler Upgrades Horace Mann Educators to Overweight, Raises Price Target to $42
Piper Sandler analyst John Barnidge upgrades Horace Mann Educators (NYSE:HMN) from Neutral to Overweight and raises the price target from $38 to $42.
JP Morgan Upgrades ZTO Express (Cayman) to Overweight, Raises Price Target to $35
JP Morgan analyst Lin Chen upgrades ZTO Express (Cayman) (NYSE:ZTO) from Neutral to Overweight and raises the price target from $27 to $35.